Teva announced its intention to divest its active pharmaceutical ingredient business to maximize current and potential revenue streams. Fourth quarter and full year 2023 figures include the impact of ...
Amid rising geopolitical tensions, Indian pharma calls for strategic overhaul of supply chain: Nandita Vijayasimha, Bengaluru Monday, January 19, 2026, 08:00 Hrs [IST] Amid rising ...
NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ...
Explore defensive investment strategies in healthcare and pharma sectors as opportunities arise amidst market volatility and ...
The Executive Order aims to bolster the resilience of the United States’s pharmaceutical supply chain by stockpiling Active Pharmaceutical Ingredients (“APIs”) for critical medicines in the Strategic ...
Aptar Pharma and Dianosic Announce Exclusive Partnership to Advance the Active Resorbable Intranasal Scaffold Platform for the Treatment of Chronic Allergic Rhinitis and Chronic Rhinosinusitis ...
New $195 million facility will further enhance AbbVie's active pharmaceutical ingredient (API) production capacity and capabilities in the U.S. Expansion is part of AbbVie's previously announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback